Skip to content

A comparative study of neuroprotective strategies in neonatal hypoxic ischaemic encephalopathy

A comparative study of neuroprotective strategies in neonatal hypoxic ischaemic encephalopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202006515915908
Enrollment
40
Registered
2020-06-22
Start date
2011-07-06
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases

Interventions

Morphine in children cooled for HIE
Cooling No Morphine

Sponsors

SAMRC
Lead Sponsor
Mary Rutherford
Collaborator
Department of Paediatrics and Child Health
Collaborator
Prof B Marais
Collaborator
Helena Rabie
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 36 weeks gestation or greater 2) Birthweight of at least 1.8kg. 3) At least one of the following: a) need for resuscitation for =10 minutes, b) Apgar score =7 at 10 minutes, c)pH =7 or base deficit =16 on cord gas or infant blood within an hour of birth. 4) Seizures, or moderate to severe encephalopathy on clinical grounds, or a Thompson HIE score of at least 10 5) Less than 6 hours old at initiation of cooling

Exclusion criteria

Exclusion criteria: 1) Less than 36 weeks 2) Birthweight less than 1.8kg. 3) Not meeting at least one of the following: a) need for resuscitation for =10 minutes, b) Apgar score =7 at 10 minutes, c)pH =7 or base deficit =16 on cord gas or infant blood within an hour of birth. 4) No Seizures and NO moderate to severe encephalopathy on clinical grounds, or a Thompson HIE score of at least 10 5) Older than 6 hours 6) congenital abnormalities 7) infants in whom intensive care is withdrawn

Design outcomes

Primary

MeasureTime frame
Primary outcome: to determine whether combining therapeutic hypothermia with another neuroprotective strategy (ie. morphine) improves survival to 18 months of age, and improves survival without major disability at 18 months of age.

Secondary

MeasureTime frame
Correlation of several biomarkers with the severity of the primary injury and outcome will be evaluated.

Countries

South Africa

Contacts

Public ContactAnita Fourie

Stellenbosch University

aec1@sun.ac.za+27219389506

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026